Cancer Help Desk的动态

Reducing morbidity related to elective colorectal cancer surgery is essential for achieving comparable oncological outcomes in the octogenarian population. Great work by Ilze Ose from Center for Surgical Science (CSS) putting emphasis on tailored preoperative optimization approach for this patient group. A lot can be gained in the future for this patient group. VELUX FONDEN https://lnkd.in/dv7McJi6

?? Exciting news in breast cancer treatment! ??? An explainable AI tool is being developed to identify patients at higher risk of adverse effects from radiation and surgery, aiding doctors in personalized treatment plans. ?? https://bit.ly/3VxFNF9 This innovative approach from international researchers aims to improve patient outcomes and reduce side effects. ?? Let's continue supporting advancements in healthcare! #Breastcancertreatment #ArtificialIntelligence(AI) #breastcancercare #Cancertreatment #breastcancercomplications #eMedEvents

Is you doctor recommended surgery for cancer treatment? What can you expect? Learn more about surgery and other treatment options: https://bit.ly/4d04CQe #CancerTreatment #PrecisionMedicine #PrecisionMedicineForCancer #BiomarkerTesting #BiomarkerTestingForCancer #CancerDiagnosis #CancerTreatmentOptions

Is you doctor recommended surgery for cancer treatment? What can you expect? Learn more about surgery and other treatment options: https://bit.ly/4d04CQe #CancerTreatment #PrecisionMedicine #PrecisionMedicineForCancer #BiomarkerTesting #BiomarkerTestingForCancer #CancerDiagnosis #CancerTreatmentOptions

Combining artificial intelligence-generated digital pathology tools, conventional histopathological assessment and circulating tumor DNA (ctDNA) analysis can improve treatment stratification of patients with colorectal cancer after surgery.

Read this paper about the new guidelines on Prostate Cancer Enjoy reading! Key findings and limitations A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50?yr of age and based on individualised life expectancy. The use of multiparametric magnetic resonance imaging in order to avoid unnecessary biopsies is recommended. When a biopsy is considered, a combination of targeted and regional biopsies should be performed. Prostate-specific membrane antigen positron emission tomography imaging is the most sensitive technique for identifying metastatic spread. Active surveillance is the appropriate management for men with low-risk PCa, as well as for selected favourable intermediate-risk patients with International Society of Urological Pathology grade group 2 lesions. Local therapies are addressed, as well as the management of persistent prostate-specific antigen after surgery. A recommendation to consider hypofractionation in intermediate-risk patients is provided. Patients with cN1 PCa should be offered a local treatment combined with long-term intensified hormonal treatment. #EAUguidelines #ProstateCancer https://lnkd.in/eZSNb46G

While today medical oncologists can build complex and more #PersonalisedTreatment strategies for #mCRC by integrating sequential chemotherapies, surgery, targeted agents and local treatments across multiple lines of therapy, patient selection is imperative to ensure good outcomes. Patient expectations and preferences must not be neglected when it comes to treatment. While novel agents continue to enrich the therapeutic armamentarium in this setting, patients expect not only longer survival times, but also better quality of life. #ESMOGI24? Read the interview with Eric Van Cutsem and Zorana Maravic about extending the continuum of care for metastatic colorectal cancer on #ESMODailyReporter? ?? https://lnkd.in/d2VpfWey

https://lnkd.in/eN9bQwBa This simple test could be a game changer for Lung Cancer early detection, further it is simple to administer at a GP Surgery. Please read this article. #worthreading #moneysaving

In this nationwide cross-sectional study of patients with breast cancer, the treatment declination rate was highest for chemotherapy and lowest for surgery, with increased trends over time in hormone therapy, radiotherapy, and surgery cohorts. https://ja.ma/4aaKjgt

Combining artificial intelligence-generated digital pathology tools, conventional histopathological assessment and circulating tumor DNA (ctDNA) analysis can improve treatment stratification of patients with colorectal cancer after surgery.